Achaogen

Achaogen is a clinical stage biopharmaceutical company focused on the discovery and development of broad-spectrum antibiotics to treat multi-drug resistant bacterial infections. The companyâ€™s most advanced drug candidate, ACHN-490, has...

Founded in 2004
Homepage: http://www.achaogen.com/
Total money raised: $82M

Headquarters

94080 7000 Shoreline Court
Suite 371
South San Francisco
USA CA

Updated on Mar 25, 2013
Achaogen at CrunchBase

Tags: anti anti-bacteria bacteria biopharma

August, 2010

Achaogen Awarded Contract Worth up to $64 Million by BARDA for the Development of ACHN-490

April, 2010

Achaogen raised $56M in a Series C round from Frazier Healthcare Ventures, Alta Partners, 5AM Ventures, ARCH Venture Partners, Domain Associates, Venrock, and Wellcome Trust

Achaogen Completes $56 Million Series C Financing

October, 2006

Achaogen raised $26M in a Series B round from Domain Associates, 5AM Ventures, ARCH Venture Partners, Venrock, and Versant Ventures

Achaogen Closes Series B Financing

2004

Achaogen was founded in 2004